Phase 1 randomized pharmacokinetic and safety study of a 90‐day tenofovir vaginal ring in the United States
Sign Up to like & getrecommendations! Published in 2024 at "Journal of the International AIDS Society"
DOI: 10.1002/jia2.26223
Abstract: Tenofovir‐based oral pre‐exposure prophylaxis is currently approved for HIV prevention; however, adherence in women has been low. A vaginal gel containing tenofovir (TFV) demonstrated partial protection to HIV but protection was not confirmed in additional… read more here.
Keywords: safety study; randomized pharmacokinetic; safety; phase randomized ... See more keywords